Phase I study of BMS-188797 in patients with advanced malignancies
Latest Information Update: 27 Sep 2005
Price :
$35 *
At a glance
- Drugs BMS 188797 (Primary)
- Indications Breast cancer; Cancer; Colorectal cancer; Non-small cell lung cancer; Renal cancer; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 27 Sep 2005 New trial record.